https://esor.eular.org
Skip to main content
1
Toggle navigation

Totara Logo ESOR

  • Close
  • Home
  • Catalog
  • Calendar

Compilation of EULAR Online Modules

Compilation of EULAR Online Modules

What do you want to learn?

Defining rheumatology trends, today

School of Rheumatology

seats left
  • General information

    General information

    EULAR has made substantial efforts and investment in developing e-learning opportunities with the newest developments in the field of rheumatology. After making a 25 EUR purchase for one module, you will have 1-year access to the module.

    Fees:
    • 1 module = 25 EUR
    • 3 modules = 50 EUR
    • 10 modules = 100 EUR


    List of Course IDs:
    • HPR: EULAR Online Course for Health Professionals in Rheumatology
    • IMG: EULAR Online Course on Imaging in RMDs
    • PAED: EULAR / PRES Online Course in Paediatric Rheumatology
    • PEP: EULAR Online Course on Patient Education
    • PRP: EULAR Online Course for Patient Research Partners
    • RMD: EULAR Course on Rheumatic Diseases
    • SLE: EULAR Online Course on Systemic Lupus Erythematosus
    • SSc: EULAR Online Course on Systemic Sclerosis

    Note: There will be no exam nor certificate upon completing the individual modules.

  • RMD: Systemic approach to diagnosis

    Educational research has shown that the main difference in clinical diagnosis between a novice and an expert clinician lies not mainly in knowledge, but in pattern recognition of the various symptoms, signs and clinical information.
  • RMD: Early arthritis: diagnosis and management

    Rheumatoid arthritis (RA) is the most common and serious chronic inflammatory disease. Untreated, it results in joint destruction, functional impairment and increased mortality.
  • IMG: Conventional radiographs: 2022 Update

    The learner will obtain familiarity with the basic principles of generating X-ray images. More specifically, they will come to understand the underlying principles of attenuation in radiographs; understand the basic principles of window width and level settings needed to view digital radiographs; and obtain familiarity with the positioning and acquisitions of radiographs of various parts of the body in rheumatic diseases. 
  • IMG: Computed tomography: 2022 Update

    This module allows the learner to gain familiarity with basic principles of generating computed tomography (CT) images, by elucidating: the underlying principles of image creation and reconstruction; the basic principles of window width and level settings; the possibility for image degradation from image artifacts and their different sources; technical advances into cone-beam CT and dual energy CT; and the inherent risks from radiation in medical imaging, especially CT. 
  • IMG: Magnetic resonance imaging: 2022 Update

    Through this module, learners come to understand: the structure of a magnetic resonance imaging (MRI) machine; the basic physical concepts in MRI; influence of MRI parameters TR and TE on image contrast; knowledge of fat suppression methods; influence of external contrast agents on image quality; patient positioning and slice orientation; and safety aspects.  
  • PEP: Patient education: General considerations

    A definition of patient education is provided in this module, along with an overview of four major pedagogical models used in this area. Various modes of communication (verbal, nonverbal, and paraverbal) are reviewed, and principles of active listening are elaborated alongside the person-centred approach. 

  • PEP: Practise of patient education

    Topics covered include: the biopsychosocial model of illness; the concept of shared decision-making; and the educational diagnosis as an unavoidable step in the patient education process.
  • PEP: Concrete realisation of a patient education programme

    This module concerns itself with the development and implementation of patient education workshops, as well as the principles of evaluation. 
  • PEP: Future of patient education

    This module elucidates the steps in the practice of patient education, and discusses research in patient education, with a focus on qualitative approaches. 
  • HPR: Inflammatory diseases

    RA is a heterogeneous condition with a variable disease course.
  • HPR: Osteoarthritis

    Osteoarthritis (OA) is the most common chronic joint disorder.
  • SSc: Treatment

    1. Strategy in patient management
    2. Patient education and lifestyle advice
    3. Rehabilitation (including hands)
    4. Management of systemic sclerosis with disease-modifying antirheumatic drugs
    5. Vasodilators
    6. Haematopoietic stem cell transplantation
  • RMD: Infection of joints and bone: Reactive Arthritis, Lyme, Whipple, HIV, ...

    This chapter gives a comprehensive view of various types of infection related arthritis.
  • SLE: Treat-to-target strategy in SLE

    This module covers: current unmet needs in the management of systemic lupus erythematosus (SLE); the general concept of treat-to-target (T2T) in SLE and in other rheumatic conditions; targeted therapies in SLE; and the concepts of remission and low disease activity in SLE. 

  • HPR: Pain syndromes

    In this module the aetiology, clinical assessment, and non-pharmacological care amongst others will be discussed.
  • HPR: Rare diseases

    Systemic sclerosis (SSc) or scleroderma is a rare, autoimmune connective tissue disease of unknown aetiology.
  • HPR: Psychosocial approaches

    This module of psychosocial aspects of rheumatic diseases consists of three parts. First, determinants of symptoms and reduced well-being and function are discussed. Second, an overview is given of outcomes that can obstruct daily life. Finally, management is discussed.
  • HPR: Assessment and evaluation

    The main focus of this module is assessment and evaluation of treatment. Assessment is understood as a planned process to gather relevant information, which thereafter guides the establishment of treatment goals and interventions.
  • HPR: Interventions

    Interventions may pertain to extended roles, such as the ordering of laboratory tests or X-rays, prescription and monitoring of drugs or the provision of intra-articular injections.
  • HPR: Evidence based practice

    The aim of this module is to provide the health professional with the practical knowledge and skills to locate the best evidence to inform clinical practice.
  • PAED: Juvenile idiopathic arthritis: Pathogenesis and clinical aspects

    Juvenile idiopathic arthritis (JIA) is not a disease but an exclusion diagnosis that gathers together all forms of arthritis that persist for more than 6 weeks, have their onset before 16 years of age and are of unknown aetiology.
  • RMD: Imaging

    To optimise the use of imaging in daily clinical practice it is important to consider advantages and disadvantages of the different imaging modalities, and also evidence for the use of each technique.
  • PAED: Treatment of Juvenile Idiopathic Arthritis

    The approach to the treatment of JIA is based on a step-up strategy, on the category of JIA to be considered, and on the level of disease activity and damage to the patient
  • PAED: Childhood-onset Systemic Lupus Erythematosus and Related Diseases

    Childhood-onset (or juvenile-onset) systemic lupus erythematosus (cSLE) is a severe, chronic, life-threatening, multi-system autoimmune disease.
  • PAED: Juvenile Dermatomyositis

    Juvenile polymyositis (JPM) is extremely rare in childhood so this chapter will focus on JDM
  • PAED: Juvenile Scleroderma

    Juvenile systemic sclerosis (JSSc) is a chronic multisystem connective tissue disorder characterised by sclerodermic skin changes and abnormalities of the visceral organs.
  • PAED: Vasculitis

    In this chapter we provide an overview of paediatric vasculitides based on the size of vessel involved.
  • PAED: Infectious and Post-Infectious Arthritis

    Septic arthritis is caused by the penetration of a viable infectious agent in the synovial space.
  • PAED: Autoinflammatory Diseases

    Autoinflammatory diseases are a distinct group of diseases that are characterised by either periodic or chronic systemic inflammation secondary to errors in the regulation of the innate inflammatory response
  • PAED: Differential Diagnosis 1: Inflammatory Diseases

    In this module, we will describe in detail the differential diagnosis of paediatric patients presenting with different clinical pictures: musculoskeletal pain/dysfunction, prolonged fever and recurrent fever.
  • PAED: Differential Diagnosis 2: Non-Inflammatory Causes of Musculoskeletal ...

    For most young people presenting to clinic, regardless of the cause of their pain, the chronic experience of it often has a large and negative impact on the physical and psychological well-being of the young person and their family.
  • IMG: B-mode MSUS and Doppler MSUS physics; indications and limits of MSUS; ...

    The following module is dealing with the basic physics of both grey-scale and Doppler ultrasound including the most important pitfalls.
  • IMG: Sonoanatomy, Scanning technique and basic pathology of the wrist and ...

    The module is focused primarily on the needs of the practising clinical rheumatologist but it is also designed for the needs of other musculoskeletal clinicians and health professionals who manage patients with hand and wrist disease.
  • IMG: Sonoanatomy, Scanning technique and basic pathology of the elbow

    This module reviews technical equipment, patient positions, probe positions, anatomical landmarks as well as the main ultrasound standard scans and basic sonopathology of the elbow.
  • RMD: Rheumatic Manifestations of Metabolic and Endocrine Disorders

    In this review we will focus on bone and joint manifestations of Langerhans cell histiocytosis (LCH).
  • RMD: The skin and the rheumatic diseases

    This chapter focuses on cutaneous manifestations observed in autoimmune rheumatic diseases, particularly lupus erythematosus (LE), dermatomyositis (DM), scleroderma, the main systemic vasculitides and rheumatoid arthritis.
  • RMD: Molecular and cellular basis of tissue destruction

    This review will focus on the molecular and cellular basis of tissue destruction in rheumatoid arthritis (RA), OA, ankylosing spondylitis (AS), and psoriatic arthritis (PsA), because, given the chronic course and the worldwide high prevalence, these disorders represent a real burden to the healthcare system.
  • RMD: Rheumatic Manifestations of Tropical Diseases

    The tropics are delimited in latitude by the Tropics of Cancer and Capricorn, and characterised by a unique climate, with heat, humidity and high rainfall in summer or throughout the year and are home to 40% of the world’s population.
  • RMD: Osteoarthritis: Pathogenesis, Clinical Aspects and Diagnosis

    Osteoarthritis (OA) is the most common chronic joint disorder. It usually results in joint pain, stiffness, deformity and loss of function, ultimately leading to chronic disability.
  • RMD: Osteoarthritis: Treatment

    Osteoarthritis (OA) is by far the most prevalent joint disease and a leading cause of disability in older adults.
  • RMD: Cervical Pain Syndromes

    Low back pain (LBP) is defined as pain related to the area between the lower ribs and the gluteal folds, with or without non-neuropathic leg pain, and is traditionally considered to affect a vast number of people (70–80%) at least once in their life
  • RMD: Low Back Pain and Associated Syndromes

    This chapter starts with a general overview of the classification of regional musculoskeletal complaints and their epidemiology.
  • RMD: Other Regional Musculoskeletal Pain Syndromes: Abdominal and Lower ...

    Pain has been shown to be the most common reason for medical consultations in the general population.
  • RMD: Other Upper Regional Musculoskeletal Pain Syndromes: Face, thorax and ...

    The skeleton is a metabolically active tissue populated by a diversity of active cells that constantly remodel bone tissue throughout life.
  • RMD: Generalised Pain Syndromes: Including Fibromyalgia and Chronic ...

    The aim of osteoporosis treatment is to prevent fragility fractures.
  • RMD: Osteoporosis: Pathogenesis and Clinical features

    This module will describe and explain the physiology of bone (bone formation, bone resorption) and bone modelling and remodelling, as well as the consequences of osteoporotic fractures: mortality, morbidity and risk for subsequent fractures.

  • IMG: Sonoanatomy, Scanning technique and basic pathology of the shoulder

    This module reviews the basic anatomy of the shoulder, the standardised US scanning technique, the basic normal US findings and abnormalities as well as the principles in handing the probe and optimizing the settings for shoulder US.
  • IMG: Sonoanatomy, Scanning technique and basic pathology of the ankle and ...

    1. Understand the indications for performing an ultrasound examination of the foot and ankle structures

    2. Know the relevant basic gross anatomy for performing a basic scan

    3. Know the standard probe positions and how to perform the EULAR standard scans
  • IMG: Sonoanatomy, Scanning technique and basic pathology of the knee

    The module is focused primarily on the needs of the practising clinical rheumatologist but it is also designed for the needs of other musculoskeletal clinicians who manage patients with rheumatic diseases involving the knee.
  • IMG: Sonoanatomy, Scanning technique and basic pathology of the hip

    1. To recognise the essential anatomy and sonoanatomy of the anterior, lateral, posterior and medial hip regions

    2. To perform a thorough ultrasound examination of these regions utilizing basic landmarks to guide in the identification and evaluation of the important structures which comprise our anatomic checklist

    3. To be able to identify synovial hypertrophy and effusion of the hip joint

  • SSc: Introduction to Systemic Sclerosis

    1. Diagnosis, differential diagnosis, evaluation of laboratory tests
    2. Localised scleroderma
    3. Epidemiology
    4. Activity
    5. The natural history of systemic sclerosis and assessment of disease severity and damage
  • SSc: Pathogenesis

    1. Synthesis early and late pathological events in scleroderma
    2. Vascular disease in systemic sclerosis (SSc)
    3. Synthesis Fibrosis in systemic sclerosis
    4. Autoantibodies, autoimmunity
    5. The genetics of systemic sclerosis
  • SSc: Clinical manifestations: Skin involvement

    1. Skin involvement
    2. Raynauds phenomenon
    3. Microvascular and macrovascular disease in sytemic sclerosis
  • SSc: Clinical manifestations: Peripheral vascular

    Covers the physiopathology and clinical manifestations of Raynaud's phenomenon; micro-and macrovascular disease in systemic sclerosis (SSc), with reference to the digits; and the main classes of vasoactive drugs, other medical therapies and non-pharmaceutical therapies in use for SSc.
  • SSc: Heart involvement

    1. Clinical consequences of functional and pathological changes
    2. Diastolic dysfunction
    3. Arrhythmia, conduction abnormalities
    4. Microvascular involvement in primary scleroderma myocardial disease
    5. Pericarditis in systemic sclerosis
  • SSc: Interstitial lung disease

    1. Pulmonary interstitial vascular involvement: interstitial lung disease associated with systemic sclerosis
    2. Pulmonary arterial hypertension associated with scleroderma
  • SSc: Pulmonary arterial hypertension

    Covers how to identify systemic sclerosis (SSc) patients at risk of pulmonary arterial hypertension (PAH). Explains why regular screening for PAH is needed in SSc, and how to use the most effective screening tools to detect PAH.
  • SSc: Clinical manifestations: GI

    1. The gastrointestinal tract in systemic sclerosis
    2. Small intestinal involvement in systemic sclerosis
    3. Colonic and anal involvement in systemic sclerosis
  • SSc: Clinical manifestations: Kidney involvement in systemic sclerosis

    Scleroderma (SSc) may cause a number of distinct abnormalities of the renal tract, but the most prominent and important manifestation is scleroderma renal crisis (SRC).
  • SSc: Clinical manifestations: Musculoskeletal and disability

    1. Joint involvement, synovitis
    2. Muscle involvement in systemic sclerosis and scleroderma–myositis overlap syndromes
    3. Hand function in systemic sclerosis
    4. Quality of life and functional disability
    5. Pain and fatigue
  • RMD: Miscellaneous inflammatory arthritides:

    1. Adult Still's
    2. Sarcoidosis
    3. Palindromic
  • SLE: The kidney in systematic lupus erethymatosus

    This module covers: the epidemiology and clinical presentation of lupus nephritis; current concepts of disease pathogenesis and histologic classification; treatment guidelines and outcomes. Clinical trial data for lupus nephritis are also summarized. 

  • SSc: Special Conditions

    1. Life-threatening conditions: emergencies in scleroderma
    2. Pregnancy and gynaecological problems in systemic sclerosis
    3. Very early and early systemic sclerosis
  • SLE: Physiopathology, epidemiology, and classification of SLE

    This introductory module addresses systematic lupus erythematosus (SLE) in terms of its incidence and prevalence. It discusses factors implicated in its pathogenesis, including environmental factors and drug-induced lupus. Important differences between adult onset SLE and juvenile SLE, characteristics of late-onset SLE, the bimodal pattern of mortality and the impact of genetic factors are also covered. 

  • SLE: Immunopathogenic mechanisms of SLE

    This module covers: main actors of innate and adaptive immunity and their abnormalities in SLE; the complex interplay between genetic and environmental factors and their interplay with innate and adaptive immunity in SLE; pleiotropic functions of type I interferon and its crucial role in initiation and perpetuation the inflammation in SLE; and genetic, epigenetic and environmental risk factors in SLE. 

  • SLE: Activity and damage indices in SLE

    The complexity of SLE presents major challenges when trying to agree disease activity and damage indices and an acceptable quality of life index. A substantial amount of work has been undertaken to devise both global score indices (e.g. the SLEDAI and ECLAM index) and the system-based BILAG index (based on the principle of the physician’s intention to treat). Only one damage index has ever been developed for lupus – the SLICC-ACR index. However, non-specific quality of life indices and lupus-specific indices are widely used to study the disease. 


  • SLE: Neuropsychiatric lupus

    This module addresses the epidemiological profile of neuropsychiatric systemic lupus erythematosus (NPSLE), as well as clinical and biological presentations of NPSLE, main peripheral syndromes of NPSLE, and how neuropsychiatric manifestations can be attributed to SLE. It covers the importance and limits of classical and advanced imaging techniques for NPSLE diagnosis and management, and appropriate management of NPSLE, depending on presentation. 

  • SLE: The joints and other organ involvement in SLE

    Provides an overview of the pathogenic mechanisms of systemic lupus erythematosus (SLE)-related musculoskeletal, hematological, lung, ocular, and gastrointestinal manifestations, with discussion of clinical presentation and laboratory characteristics. Complications of these manifestations are also considered, along with outcomes and management. 


  • SLE: Antiphospholipid Syndrome

    Historical and epidemiological profiles of the antiphospholipid syndrome (APS) and its catastrophic variant are explored. Pathogenic mechanisms of the antiphospholipid antibodies (aPL) are discussed, including inhibition of anticoagulant reactions, cell-mediated events, monocytes and complement. Clinical presentation, laboratory characteristics, classification criteria, therapeutic approaches and outcomes of APS are also included. 


  • SLE: The heart and the blood in SLE

    This module is concerned with epidemiological and clinical evidence for increased risk of cardiovascular disease (CVD) and haematological disorders in patients with systemic lupus erythematosus (SLE). Risk factors, pathogenic mechanisms, the role of biomarkers, therapeutic approaches and outcomes are discussed.
  • SLE: Pregnancy in SLE

    The interaction of pregnancy with systematic lupus erythematosus (SLE) is explored. Specific maternal and fetal problems in SLE pregnancy are covered, along with subgroups of patients with particular implications, the use of anti-rheumatic drugs during pregnancy and lactation, and the importance of multidisciplinary management of pregnant SLE patients. 

  • SLE: Cutaneous lupus

    Covers skin manifestations in systematic lupus erythematosus (SLE), including the risk of systemic involvement in the different variants of cutaneous lupus erythematosus (CLE). Possible conditions associated with subactute CLE, and treatment of skin manifestations in patients with SLE are explored. Non-specific cutaneous lesions of SLE and their prognostic and therapeutic relevance are also discussed.  
  • Capillaroscopy: Microcirculation in RMDs: overview in health and disease

    Covers anatomy of microcirculation and pathophysiology of microcirculation in RMDs. Subsequently provides an overview of major clinical symptoms of altered microcirculation in the following conditions: Systemic sclerosis; dermatomyositis; psoriasis and psoriatic arthritis; rheumatoid arthritis; systemic lupus erythematosus; antiphospholipid syndrome; vasculitis. 

  • Capillaroscopy: The diagnostic tools to evaluate the Microcirculation in ...

    Explores the tools used to measure structural and functional aspects of the skin’s microcirculation in RMDs, including required ambient conditions and the dynamic tests performed alongside them. Different tools are compared in terms of their advantages and disadvantages. Discussion of how these tools have been used in studies to elucidate the role of the microcirculation in Raynaud's phenomenon and SSc is also included. 

  • RMD: Connective tissue diseases: Concepts and pathogenesis, overlap ...

    The following article will shed light on the subtle differences among these three rheumatic entities; it will explain the different organ manifestations and risks for severe complications.
  • RMD: Systemic Lupus Erythematosus: Pathogenesis, clinical manifestations ...

    Systemic lupus erythematosus presents with a broad spectrum of symptoms encompassing almost all organs and a chronic course, which can vary from mild to life-threatening.
  • RMD: Systemic Lupus Erythematosus: Treatment

    During the last two decades, major improvements in the treatment of SLE can be mainly attributed to a better use of traditional immunosuppressive drugs.
  • RMD: Pregnancy-Related Problems in Rheumatic Diseases, Including the ...

    This chapter describes the maternal course of several common and some rare rheumatic diseases during pregnancy, fetal outcome and treatment during pregnancy and post-partum.
  • RMD: Systemic Sclerosis

    Systemic sclerosis (SSc) is a connective tissue disease characterised by fibrosis of the skin and internal organs, pronounced alterations in the microvasculature and frequent cellular and humoral immunity abnormalities.
  • RMD: Idiopathic inflammatory myopathies

    Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune, rare and heterogeneous muscle disorders characterized by the occurrence of proximal and symmetrical muscle weakness, which can result in impaired endurance and disability.
  • RMD: Sjörgen's Syndrome

    Sjögren syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine glands. This leads to dryness of the main mucosal surfaces, such as the mouth, eyes, skin, nose, pharynx, larynx and vagina (Ramos-Casals et al, 2012a).
  • RMD: Vasculitis: Classification, Secondary Forms and Mimics

    This chapter describes the current schemes for classifying and defining the systemic vasculitides.
  • RMD: ANCA-associated vasculitis and polyarthritis nodosa

    For this chapter, readers should be aware of the classification and consensus definitions of the primary necrotising vasculitides, mainly the revised Chapel Hill nomenclature, and the recent changes in the names for some of them.
  • RMD: Rheumatoid arthritis: pathogenesis, clinical aspects and diagnosis

    Rheumatoid arthritis (RA) is a chronic inflammatory disorder that typically affects small and medium-sized joints symmetrically.
  • RMD: Rheumatoid arthritis: Treatment

    Indeed, for many decades, the therapeutic approach was to adopt a cautious ‘wait and see’ strategy in the initial stages of the disease and keep the most effective – or the least ineffective – therapies for more advanced stages.
  • RMD: Immunology and the Rheumatic Diseases

    This module is designed to provide simple and basic knowledge of immunology of relevance to the pathogenic pathways that underpin autoimmune rheumatic disease.
  • RMD: Spondylarthropathies: pathogenesis,clinical aspects and diagnosis

    Spondyloarthritis (SpA) is a heterogeneous group of chronic inter-related inflammatory arthropathies affecting mainly the spine but also showing peripheral symptoms in the joints, entheses and certain extra-articular sites.
  • RMD: Spondylarthropathies: treatment

    Spondyloarthritis (SpA) is a group of arthropathies comprising ankylosing spondylitis (AS), reactive arthritis, arthritis/spondylitis associated with psoriasis, and arthritis/spondylitis associated with inflammatory bowel disease (IBD).
  • RMD: Measure of disease activity and damage in inflammatory arthritis

    The content focuses on the application in clinical practice and the interpretation of published data from studies.
  • RMD: Juvenile Idiopathic Arthritis (JIA)

    Juvenile idiopathic arthritis (JIA) is not a single disease but a diagnosis that applies to all forms of arthritis of unknown origin, with onset prior to the 16th birthday, lasting more than 6 weeks and where other causes of arthritis have been excluded (Martini, 2012*).
  • Capillaroscopy: when to perform and how to evaluate, optimise and report ...

    This module gives a brief history of capillaroscopy, and then the capillaroscopic analysis is discussed in detail, including material and methods, acclimatisation and positioning of patients, and the most common mistakes made in reading capillaroscopic images. Standardised interpretation of capillaroscopic images is also covered. 

  • RMD: Crystal arthropathies

    Gout is an inflammatory disease caused by the deposition of monosodium urate (MSU) crystals in joints and other tissues.
  • RMD: Clinical epidemiology - Critical appraisal of evidence

    This chapter concentrates on the critical appraisal of randomised controlled trials (RCTs), of meta-analyses of RCTs and of studies of diagnostic test accuracy.
  • RMD: Genetic Aspects of Rheumatic Diseases

    This module aims to increase the understanding of genetics in order that the reader will be able to evaluate genetic studies critically.
  • RMD: Psychosocial Aspects of the Rheumatic Diseases

    It is important that clinicians pay attention to the psychosocial, behavioural and contextual as well as biological aspects of rheumatic diseases, as these processes are inextricably linked and affect the perception of, and response to, symptoms and related disability.
  • RMD: Clinical Epidemiology - Impact of the Rheumatic Diseases

    Understanding the epidemiology and impact of various RMDs will give a better understanding of the causes, risk factors and outcomes of RMDs.
  • RMD: Behcet's Disease, Relapsing Polychondritis and Eye Symptoms in ...

    Although there has been global interest in Behçet’s disease (BD) during the past two decades, the condition has been recognised since antiquity and was described by Hippocrates.
  • RMD: Polymyalgia Rheumatica and Giant Cell Arteritis

    Polymyalgia rheumatica (PMR) is an inflammatory disorder characterised by pain, aching and morning stiffness in the shoulder girdle and often in the pelvic girdle and neck.
  • RMD: Systemic Consequences of the Inflammatory Process

    Various forms of amyloidosis are characterised by extracellular deposition of fibrillar proteins.
  • RMD: Autoinflammatory syndromes

    This chapter will give an overview of the pathogenesis, clinical picture and treatment of the most common or best described autoinflammatory diseases.
  • RMD: Systemic manifestions of primary immune deficiencies and FAS ...

    This chapter follows the structure of the International Union of Immunological Societies, which is revised every 2 years; the last version issued in 2015 can be consulted for the most recent list of all classified PIDs.
  • RMD: Malignant bone diseases (as they apply to rheumatic diseases)

    This chapter will discuss the two main malignant bone disorders of adulthood: multiple myeloma and bone metastases, while focusing on the bone-related aspects of the diseases, from the pathogeny to the care of these diseases.
  • RMD: Pain: mechanisms and management

    This chapter will cover our current understanding of the neurophysiological mechanisms underlying nociception, the clinical manifestations of different types of pain and the biopsychosocial approach to the management of pain.
  • RMD: Rehabilitation aspects of rheumatic diseases

    This chapter has been developed from the perspective of the rheumatologist and includes issues and tasks he or she needs to know and carry out for the rehabilitation of patients with rheumatic conditions.
  • RMD: Glucocorticoids

    In this chapter, we focus on the characteristics of glucocorticoids and the therapeutic effects and adverse effects which are frequently seen in clinical practice
  • RMD: Cryoglobulinaemia and Hepatitis C Virus

    The presence in the serum of one (monoclonal cryoimmunoglobulinaemia) or more immunoglobulins (mixed cryoglobulinaemia, MC) is termed cryoglobulinaemia or cryoimmunoglobulinaemia and is an in vitro phenomenon.
  • RMD: Cell and gene therapy in rheumatic diseases

    This chapter describes the last insights about cell and gene therapy in rheumatic diseases, from the basis of the techniques to their potential application in clinical practice.

    The main topics are:

    -The application of mesenchymal and hematopoietic stem cell transplantation in rheumatic diseases;

    -The latest advances in gene therapy in rheumatic diseases;

    -The potential applications of the technology of chimeric antigen receptor (CAR) T cells for the cure of rheumatic diseases.

  • RMD: Neuro-endocrineimmunology

    1. Describe the significance of the neuroendocrine immune network as a common system in rheumatic diseases
    2. Explain the role of adrenal and gonadal steroid hormones, as well as neurotransmitters in the immune response and inflammation modulation in rheumatic diseases
    3. Describe the role of the sympathetic nervous system in arthritis
  • RMD: Nutrition in Rheumatic & Musculoskeletal Diseases

    1. Describe the optimal nutritional components and life style to prevent the adoption of unhealthy diets that might act as a risk factor to rheumatic and musculoskeletal diseases (RMDs) development and progression
    2. Understand the role of nutrients and beverages in disease course and expression of RMDs
    3. Learn about advantages/disadvantages of different diets including the Mediterranean diet and their role in pregnancy and in RMDs
  • PAED: General aspects of childhood and adolescence

    Bone formation and skeletal growth are described in this section.
  • IMG: Conventional radiographs in RA

    Contains:
    • Conventional radiographs in RA - Basic Principles
    • Recognising typical rheumatoid arthritis pathology using conventional radiography
  • IMG: Conventional radiographs in PsA

    Psoriasis arthritis (PsA) belongs to the group of seronegative spondylarthropathies and can present as a mono- or polyarthritic joint disease that even can mimic the symmetric polyarticular pattern of rheumatoid arthritis (RA).
  • IMG: Conventional radiographs in axSpA

    This chapter primarily will focus on radiography of the sacroiliac joints.
  • IMG: Conventional radiographs in OA

    Recognising typical osteoarthritis pathology using conventional radiographs
  • IMG: Computed Tomography in RA

    Recognising typical RA pathology using CT.
  • IMG: Computed Tomography in PsA

    In this module, we will discuss primarily the peripheral manifestations of psoriatic arthritis (PsA).
  • IMG: Computed Tomography in axSpA

    Recognising typical axSpA pathology using CT
  • IMG: Computed Tomography in OA

    Osteoarthritis (OA) is the most common joint disease and a leading cause of physical disability.
  • IMG: Magnetic Resonance Imaging in RA

    Contains:
    • Basic concepts of Magnetic Resonance Imaging (MRI) in Rheumatology
    • Recognizing typical RA pathology using MRI
  • IMG: Magnetic Resonance Imaging in PsA

    Recognising typical psoriatic arthritis pathology using magnetic resonance imaging
  • IMG: Magnetic Resonance Imaging in axSpA

    Due to its diagnostic importance, this chapter will primarily focus on MRI of the sacroiliac joints.
  • IMG: Magnetic Resonance Imaging in OA

    Recognizing Typical OA Pathology Using MRI
  • PRP: Principles of collaborative research

    The aim of this module is to introduce the learner to collaborative research, to help them become aware of the value of their own experiential knowledge and expertise in the context of rheumatology research, and to show how patient research partners can provide their unique perspective to scientific projects.

  • PRP: Basic epidemiology

    This module covers the basic concepts of epidemiology. Learners will: become familiar with the empirical research cycle; understand how to differentiate between different types of health research; learn how to interpret the validity of data using the pyramid of evidence; and learn to recognise the meaning of different types of tables and graphs. 

  • PRP: Outcome measures in rheumatology and the role of PRPs

    The learner will obtain insights into the most commonly used outcome measures in rheumatology. The learner will also become able to contribute confidently the patient perspective to the development, validation and selection of relevant outcomes in clinical research.


  • PRP: Critical appraisal of scientific publications

    The learner will obtain the basic skills to search, understand and critically appraise a scientific paper.


  • HPR: Basics and principles of evidence-based practice

    Covers basic elements on Evidence Based Practice (EBP), including how to practice EBP, the integration of the evidence found in the clinical reasoning process, and the dimensions of critical appraisal.
  • HPR: Turning the information needs into clinical questions that can be ...

    Covers background questions and foreground questions, and how to turn information needs into clinical questions that can be answered. 
  • HPR: Find the best evidence available to answer the question

    Main topics covered include: primary and secondary study designs; sources of biomedical information; Cochrane library; and PubMed (MEDLINE). 
  • HPR: Critical appraisal of scientific literature, regarding validity, ...

    Covers clinical trials classification, main sources of bias, outcome classification, relative and absolute outcome measures, as well as critical appraisal of validity, relevance and applicability. 
  • HPR: Critical appraisal of scientific literature, regarding validity, ...

    Main topics include: systematic reviews and narrative reviews; systematic review classification, qualitative synthesis and meta-analysis; forest-plot, heterogeneity and additional analysis, as well as critical appraisal of validity (AMSTAR 2), relevance and applicability.
  • HPR: Critical appraisal of scientific literature, regarding validity, ...

    Covers main sources of bias; diagnostic accuracy measures; Fagan's nomogram, and critical appraisal of validity (CASP-tool), relevance and applicability.
  • HPR: Guidelines, recommendations and points to consider for use in ...

    Includes: guidelines; main sources of bias; the GRADE approach; and interpretation of recommendations. 

FAQ

CONTACT US

Terms & Conditions

Legal Disclaimer

Complaint Procedure